[1] Bonita R, Mendis S, Truelsen T, et al. The global stroke initiative. Lancet Neurol, 2004; 3, 391-3. doi:  10.1016/S1474-4422(04)00800-2
[2] Strong K, Mathers C, Bonita R. Preventing stroke:saving lives around the world. Lancet Neurol, 2007; 6, 182-7. doi:  10.1016/S1474-4422(07)70031-5
[3] Feigin VL. Stroke epidemiology in the developing world. Lancet, 2005; 365, 2160-1. doi:  10.1016/S0140-6736(05)66755-4
[4] He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med, 2005; 353, 1124-34. doi:  10.1056/NEJMsa050467
[5] Della-Morte D, F Guadagni, R Palmirotta, et al. Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics, 2012; 13, 595-613. doi:  10.2217/pgs.12.14
[6] O'Donnell MJ, D Xavier, L Liu, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study):a case-control study. Lancet, 2010; 376, 112-23. doi:  10.1016/S0140-6736(10)60834-3
[7] Sacco RL. Newer risk factors for stroke. Neurology, 2001; 57, S31-4. doi:  10.1212/WNL.57.suppl_2.S31
[8] Liao D, R Myers, S Hunt, et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke, 1997; 28, 1908-12. http://www.biomedcentral.com/content/xml/1471-2377-5-20.xml
[9] Flossmann E, UG Schulz, PM Rothwell. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke, 2004; 35, 212-27. http://circgenetics.ahajournals.org/content/5/2/226
[10] Seshadri S, A Beiser, A Pikula, et al. Parental occurrence of stroke and risk of stroke in their children:the Framingham study. Circulation, 2010; 121, 1304-12. doi:  10.1161/CIRCULATIONAHA.109.854240
[11] Kaptoge S, E Di Angelantonio, G Lowe, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality:an individual participant meta-analysis. Lancet, 2010; 375, 132-40. doi:  10.1016/S0140-6736(09)61717-7
[12] Kuo HK, CJ Yen, CH Chang, et al. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population:systematic review and meta-analysis. Lancet Neurol, 2005; 4, 371-80. doi:  10.1016/S1474-4422(05)70099-5
[13] Ridker PM, JE Buring, J Shih, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998; 98, 731-3. doi:  10.1161/01.CIR.98.8.731
[14] E L, N Fragakis, E Ioannidou, et al. Increased levels of proinflammatory cytokines in children with family history of coronary artery disease. Clin Cardiol, 2010; 33, E6-10. https://www.ncbi.nlm.nih.gov/pubmed/20229495
[15] Perloff D, C Grim, J Flack, et al. Human blood pressure determination by sphygmomanometry. Circulation, 1993; 88, 2460-70. doi:  10.1161/01.CIR.88.5.2460
[16] 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. Hypertension, 1993; 22, 392-403.
[17] Sitzmann FC, P Eschler. Enzymatic determination of blood glucose with a modified hexokinase method. Med Klin, 1970; 65, 1178-83. https://www.ncbi.nlm.nih.gov/pubmed/5517345
[18] Allain CC, LS Poon, CSG Chan, et al. Enzymatic determination of total serum cholesterol. Clin Chem, 1974; 20, 470-5. doi:  10.1021/ed055p63?src=recsys
[19] Friedewald WT, RI Levy, DS Fredrickson. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18, 499-502. https://www.ncbi.nlm.nih.gov/pubmed/4337382
[20] Tang L, T Xu, H Li, et al. Hypertension, alcohol drinking and stroke incidence:a population-based prospective cohort study among inner Mongolians in China. J Hypertens, 2014; 32, 1091-6. doi:  10.1097/HJH.0000000000000142
[21] Stroke——1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke, 1989; 20, 1407-31.
[22] Pearson TA, GA Mensah, RW Alexander, et al. Markers of inflammation and cardiovascular disease:application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107, 499-511. doi:  10.1161/01.CIR.0000052939.59093.45
[23] Ridker PM, M Cushman, MJ Stampfer, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336, 973-9. doi:  10.1056/NEJM199704033361401
[24] Brass LM, LA Shaker. Family history in patients with transient ischemic attacks. Stroke, 1991; 22, 837-41. doi:  10.1161/01.STR.22.7.837
[25] Siegerink B, FR Rosendaal, A Algra. Family history differs between young women with myocardial infarction and ischemic stroke:results from the RATIO case-control study. Atherosclerosis, 2012; 223, 235-8. doi:  10.1016/j.atherosclerosis.2012.04.024
[26] Elkind MS, JM Luna, YP Moon, et al. High-sensitivity C-reactive protein predicts mortality but not stroke:the Northern Manhattan Study. Neurology, 2009; 73, 1300-7. doi:  10.1212/WNL.0b013e3181bd10bc
[27] van Dijk EJ, ND Prins, SE Vermeer, et al. C-reactive protein and cerebral small-vessel disease:the Rotterdam Scan Study. Circulation, 2005; 112, 900-5. doi:  10.1161/CIRCULATIONAHA.104.506337
[28] Curb JD, RD Abbott, BL Rodriguez, et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation, 2003; 107, 2016-20. doi:  10.1161/01.CIR.0000065228.20100.F7
[29] Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among U. S. adults. Epidemiology, 2002; 13, 561-8. http://circgenetics.ahajournals.org/content/7/2/178
[30] Esposito K, R Marfella, M Ciotola, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome:a randomized trial. Jama, 2004; 292, 1440-6. doi:  10.1001/jama.292.12.1440
[31] Albert MA, E Danielson, N Rifai, et al. Effect of statin therapy on C-reactive protein levels:the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study. Jama, 2001; 286, 64-70. doi:  10.1001/jama.286.1.64
[32] Esenwa CC, MS Elkind. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol, 2016; 12, 594-604. doi:  10.1038/nrneurol.2016.125